Stocksigma LogoStocksigma Logo

Krsnaa Diagnostics Receives In-Principle Approval for Convertible Warrants Issue

Krsnaa Diagnostics secured in-principle approval from BSE and NSE on 8th Oct'26 for the preferential issuance of 16,21,000 convertible warrants to its

Krsnaa Diagnostics Receives In-Principle Approval for Convertible Warrants Issue

Krsnaa Diagnostics Ltd 路 Others (Uncategorized) 路 09 Oct 2026, 2:45 am

Krsnaa Diagnostics Receives In-Principle Approval for Convertible Warrants Issue Krsnaa Diagnostics secured in-principle approval from BSE and NSE on 8th Oct'26 for the preferential issuance of 16,21,000 convertible warrants to its Promoter and Promoter Group. Each warrant is convertible into one equity share of face value Rs. 5 at an issue price of Rs. 566 per share. While NSE approval is finalized, BSE's letter contains factual errors undergoing rectification, with the corrected version to be submitted upon receipt.

Original exchange filing (PDF)

More announcements from Krsnaa Diagnostics Ltd

All Krsnaa Diagnostics Ltd announcements